Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(6 sites)

Denmark

Aalborg University Hospital, Aalborg

The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen

Herlev and Gentofte University Hospital - Gentofte, Hellerup

Odense University Hospital, Odense

Zealand University Hospital, Roskilde

Aarhus University Hospital, Skejby